Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 12, 2025Epidemiology Biostatistics and Public HealthOpen Access

Treatment Strategies of Acute Myeloid Leukemia Relapses after Allogeneic Stem Cell Transplantation: Evidence from the GITMO Nationwide Italian Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDomenica MatrangaMMMichele MalagolaLCLuca Castagna

Discussion

Loading...

Member takes

Overview

Observational analysis identified disease burden influencing overall survival in AML patients after allogeneic SCT, highlighting effective treatment approaches.

Key Points

  • Overall survival was significantly improved in patients with low disease burden receiving DLI-based therapy.
  • Among 859 AML/MDS relapsed cases, 75% received treatment, with hypomethylating agents used in nearly 48% of cases.
  • Multivariate analysis revealed that low disease burden at relapse was independently linked to better overall survival and reduced relapse mortality.
  • Delaying post-relapse treatment until advanced stages was common, emphasizing the need for early intervention to improve outcomes.

Cite This Study

Matranga et al. (2025) studied this question.

synapsesocial.com/papers/68d41eca713b0b5dfea67598https://doi.org/10.54103/2282-0930/29561
View Full Paper
Ask AI
Bookmark
Share